Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Omega (Westport) ; : 302228241254001, 2024 May 14.
Article in English | MEDLINE | ID: mdl-38744535

ABSTRACT

The number of parents in China who have lost their only child, referred to as shidu parents, currently exceeds one million and is increasing by approximately 76,000 annually. Shidu parents face a unique challenge in long-term care, primarily stemming from the sudden and tragic loss of their only child, which leads to a substantial decrease in their social support network. A multi-stage, stratified, and cluster sampling method was employed across various economic belts. Linear regression analysis was utilized to examine factors associated with the social support status of shidu and non-shidu parents. The level of social support decreases as the severity of depression increases. Shidu parents with grandchildren tend to have good social support. The city of Hangzhou exhibits relatively high levels of social support. Married individuals typically report higher levels of social support. It is recommended to prioritize shidu parents without grandchildren as a primary focus for government and societal support. Key recommendations include strengthening social skills training and developing social support networks. Drive economic development, particularly in relatively underdeveloped regions. Strengthen social organizations and community development. Enhancing access to support services, leveraging technology, and encouraging volunteerism for non-married parents.

2.
Bioorg Med Chem ; 23(10): 2562-7, 2015 May 15.
Article in English | MEDLINE | ID: mdl-25865131

ABSTRACT

A series of open-chain analogs of cyclic peptides was designed and synthesized using sansalvamide A as a model compound. All compounds exhibited low antitumor activity. Furthermore, the evaluation of their inhibitory potency toward IMPDH, SHP2, ACHE, proteasome, MAGL, and cathepsin B showed that all of the compounds were potent against protein tyrosine phosphatase Shp2. Specifically, compounds 1a, 1d, 2b, and 2f were found to inhibit SHP2 with IC50 values in the low micromolar range and good selectivity. Based on the molecular docking results, the binding modes of the chain cyclic peptides in the active center of SHP2 were discussed.


Subject(s)
Enzyme Inhibitors/chemical synthesis , Peptides, Cyclic/chemical synthesis , Protein Tyrosine Phosphatase, Non-Receptor Type 11/antagonists & inhibitors , Acetylcholinesterase/chemistry , Catalytic Domain , Cathepsin B/antagonists & inhibitors , Cathepsin B/chemistry , Cell Line, Tumor , Cell Proliferation/drug effects , Enzyme Assays , Enzyme Inhibitors/pharmacology , GPI-Linked Proteins/antagonists & inhibitors , GPI-Linked Proteins/chemistry , Gene Expression , HeLa Cells , Humans , IMP Dehydrogenase/antagonists & inhibitors , IMP Dehydrogenase/chemistry , Kinetics , Molecular Docking Simulation , Peptides, Cyclic/pharmacology , Proteasome Endopeptidase Complex/drug effects , Proteasome Endopeptidase Complex/metabolism , Protein Binding , Protein Tyrosine Phosphatase, Non-Receptor Type 11/chemistry , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...